Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, June 2001, p. 1743-1745, Vol. 45, No. 6
Division of Infection & Immunity, Institute of Biomedical
and Life Sciences, University of Glasgow, Glasgow G12
8QQ,1 and Wellcome Centre for
Molecular Parasitology, The Anderson College, University of
Glasgow, Glasgow G11 6NU,2 United Kingdom
Received 26 January 2001/Returned for modification 5 March
2001/Accepted 21 March 2001
Methionine
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.6.1743-1745.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Trifluoromethionine, a Prodrug Designed against
Methionine
-Lyase-Containing Pathogens, Has Efficacy In Vitro
and In Vivo against Trichomonas vaginalis
-lyase, the enzyme which catalyzes the single-step
conversion of methionine to
-ketobutyrate, ammonia, and
methanethiol, is highly active in many anaerobic pathogenic
microorganisms but has no counterpart in mammals. This study tested the
hypothesis that this pathogen-specific enzyme can be exploited as a
drug target by prodrugs that are exclusively activated by it.
Trifluoromethionine was confirmed as such a prodrug and shown to be
highly toxic in vitro to the anaerobic protozoan parasite
Trichomonas vaginalis, to anaerobic bacteria containing
methionine
-lyase, and to Escherichia coli expressing
the trichomonad gene. The compound also has exceptional activity
against the parasite growing in vivo, with a single dose preventing
lesion formation in five of the six mice challenged. These findings
suggest that trifluoromethionine represents a lead compound for a novel
class of anti-infective drugs with potential as chemotherapeutic agents
against a range of prokaryotic and eukaryotic anaerobic pathogens.
*
Corresponding author. Mailing address: Division of
Infection & Immunity, University of Glasgow, Joseph Black Building,
Glasgow G12 8QQ, United Kingdom. Phone: 44 141 330 4777. Fax: 44 141 330 3516. E-mail: g.coombs{at}bio.gla.ac.uk.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»